Medtronic , a global leader in surgical innovation, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugotm robotic-assisted surgery (RAS) system for use in urologic ...

Medtronic plc MDT has begun the broad U.S. commercial rollout of the MiniMed 780G system integrated with Abbott’s ABT Instinct sensor, designed exclusively for MiniMed systems. Earlier this year, the ...

When used in conjunction with the MiniMed 780G system, the sensor is said to deliver real-time glucose data.

The Instinct sensor is based on Abbott's most advanced CGM technology and provides real-time glucose readings, which the system uses to automate insulin adjustments every five minutes.

Otsuka leads in market share with 16% of global revenue, while Stryker, Medtronic and Dexcom are well-positioned as the ...

Medtronic (NYSE:MDT) announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G ...

Investing.com -- Morgan Stanley expects the MedTech industry to enter 2026 on stronger footing, supported by new product cycles, improving margins and higher capital spending by hospitals. Volatility ...

Medtronic FCA Claims Survive Reconsideration Despite First Circuit’s But-For Causation Standard - A Massachusetts federal court ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

According to DataM Intelligence, the U.S. Software as a Medical Device (SaMD) Market Size reached USD 205.12 million in 2024 ...

The Global Intravenous Catheters Market is on a steady growth trajectory, driven by rising healthcare demands, an aging population, and continuous innovation in intravenous (IV) therapy technologies.